Biocomposites, an international medical device company that engineers, manufactures and markets products for use in infection management in bone and soft tissue, has launched Biocomposites Companion, one of the first of a new generation of user apps, designed to help surgeons and their support staff make the most of its products, Stimulan and genex at the point of use in a surgical procedure.
The current Coronavirus pandemic has affected many aspects of clinical practice highlighting the need for hospitals, surgeons and their sales representatives to adapt. Biocomposites Companion app ensures all Stimulan and genex users have access to important information on demand as they develop and execute their patient specific infection management strategies.
Michael Harris, chief executive officer of Biocomposites, said: “The number of surgeons we serve at Biocomposites is growing rapidly around the world, and the impact of COVID-19 on clinical practice has made it difficult for our sales representatives to be present in the operating room, and provide guidance to the surgeon during a procedure. To alleviate these pressures and maintain our unrivalled levels of support, the Biocomposites Companion app puts product preparation information, setting times and tips directly into the hands of the operating room staff. We are passionate about driving improved outcomes for surgeons and patients alike and the launch of the app is another step forward in that endeavour.”
Mr Abhijit Bhosale, consultant orthopaedic foot and ankle surgeon, Barnsley Hospital, added: “I think the Companion app is really easy to use and has all the info I need. It is a great help before my surgeries to refresh my memory about the products. What I like most are the preparation videos, antibiotic setting times and the top tips – which are always important.”
